Whoop
Whoop makes a screenless wearable band that tracks sleep, recovery, and strain for a subscription fee.
The call
Whoop is growing fast and generating cash, but Apple already ships the AI coaching it's known for and Oura has passed it in brand awareness while both race toward IPOs.
Whoop makes a wearable device that tracks your body signals and gives you personalized health coaching powered by artificial intelligence. It is not particularly hard for competitors to copy or replace: Apple already makes a similar product and has way more customers, while Oura is growing just as fast and more people have heard of Oura than Whoop. The one thing that could change everything is if Whoop can partner with hospitals and doctors to turn its tracker into an actual medical device approved by the FDA, which would be much harder for Apple or Oura to do quickly.
Why
01
AI pressure: Apple Workout Buddy (watchOS 26). Apple's AI coaching rides on 200M+ existing watches, and Whoop's own AI coach runs on OpenAI's model, not something it owns. Could AI do the core job? Only partly.
02
Bigger players: Apple. Apple holds about 52% of health wearable shipments and keeps adding the coaching and recovery features that used to be Whoop's reason to exist. Could a giant copy it? Yes, easily.
03
What protects it. Deep multi-year strain and recovery data on 2.5 million members, plus early Mayo Clinic and Abbott ties aimed at real medical clearance.
What would change this call
Whoop files an S-1 or confidentially registers for IPO within 12-24 months. Confirms CEO's stated IPO path and tests public market appetite versus Oura.
FDA clears a Whoop medical feature and payer/employer contracts are announced. Shows the clinical/regulatory moat is real, not just marketing.
Apple ships a screenless companion band or standalone health-focused wearable. Would directly target Whoop's core screenless-recovery niche.
FDA clears a Whoop medical feature and payer/employer contracts are announced. Shows the clinical/regulatory moat is real, not just marketing.
Apple ships a screenless companion band or standalone health-focused wearable. Would directly target Whoop's core screenless-recovery niche.
Key numbers
- $1.1B run rate, up 103% YoY
- Oura leads brand awareness 41.7% vs Whoop 35.7%
- Apple holds about 52% of wearable shipments
Named risks
- Class action Rowe v. Whoop over 'medical-grade' Blood Pressure Insights marketing remains unresolved as of June 2026.
- Core AI coaching layer depends on a rented third-party LLM rather than proprietary AI.
- Oura and Apple both closing brand and feature gap, eroding Whoop's performance-niche positioning.
- 75% headcount expansion in 2026 while preparing a possible IPO creates execution and integration risk.
- Regulatory ambiguity around wellness vs medical device classification persists industry-wide despite FDA closing its Whoop warning letter.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Apple | losing to | Apple held ~52% of new health-wearable shipments and shipped AI Workout Buddy coaching in watchOS 26, 2025 to 2026 |
| Oura | losing to | Oura overtook Whoop in US brand awareness, 41.7% vs 35.7%, as of June 2026 |
| Oura | contesting | Both near revenue parity: Whoop $1.1B run rate at 103% YoY vs Oura ~$1B TTM at ~100% YoY, per Sacra, April 2026 |
| Garmin | contesting | Garmin posted $7.3B 2025 revenue growing 15% YoY, far larger scale but slower growth than Whoop |
| Fitbit/Google | losing to | Fitbit holds 85.9% brand awareness versus Whoop's 35.7% as of 2026 |
Questions people ask
- Is Whoop profitable in 2026?
- Whoop says it was operating cash-flow positive in 2025, with 2025 bookings up 103% year-over-year and exiting the year at roughly a $1.1B annualized run rate, per its March 31, 2026 Series G funding announcement.
- Is Whoop planning an IPO?
- CEO Will Ahmed said the March 2026 $575M Series G, which valued Whoop at $10.1B, is expected to be the company's last private round, with an IPO as the next step within roughly 12 to 24 months of mid-2026, per Yahoo Finance, March 31, 2026.
- Who is Whoop's biggest competitor?
- Whoop faces Apple, which held about 52% of new health-tracking wearable shipments and shipped AI 'Workout Buddy' coaching in watchOS 26, and Oura, which overtook Whoop in US brand awareness (41.7% vs 35.7%) by June 2026.
- Could AI replace Whoop's coaching feature?
- Whoop's coaching layer runs on a third-party LLM, originally OpenAI's GPT-4 since September 2023 and still a third-party model in its April 2026 'My Memory' upgrade, meaning the natural-language layer itself is not proprietary AI, per whoop.com, April 29, 2026.
- Is Whoop laying off workers in 2026?
- No, Whoop announced in March 2026 plans to add 600+ new roles in 2026, a roughly 75% headcount increase targeting about 1,400 employees, mostly in Boston, after cutting 15% of staff in 2022, per the Boston Globe, March 4, 2026.
- Has Whoop had legal or regulatory trouble?
- Yes. The FDA sent Whoop a warning letter in July 2025 over its Blood Pressure Insights feature, and a class action, Rowe v. Whoop, was filed November 18, 2025 alleging false 'medical-grade' advertising; the FDA closed its warning letter in June 2026 after Whoop modified the feature.
Timeline
- 2026-07-22Whoop hires ex-FDA Digital Health Advisory Committee chair Dr. Ami Bhatt as incoming CMO
- 2026-06-24FDA closes warning letter against Whoop after it modifies Blood Pressure Insights
- 2026-05-21Oura files confidentially for a US IPO
- 2026-05-08Whoop adds on-demand clinician access and new AI features
- 2026-04-29Whoop rolls out 'My Memory' AI coaching upgrade still on third-party LLM
- 2026-03-31Whoop closes $575M Series G at $10.1B valuation, cites $1.1B run rate
- 2026-03-04Whoop announces plan to add 600+ roles, targeting ~1,400 employees
- 2025-11-18Class action Rowe v. Whoop filed over Blood Pressure Insights marketing
- 2025-09-30Whoop launches Advanced Labs integrating clinical blood-test data
- 2025-07-31FDA issues warning letter to Whoop over Blood Pressure Insights
Revision history
22 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- WHOOP Raises $575 Million at $10.1 Billion Valuation to Advance Global Health Platform (2026-03-31)
- $1.1B/year Under Armour of health wearables (2026-04-14)
- Whoop CEO after raising $575 million (2026-03-31)
- Consumer Health IPO Wave Outlook
- Whoop hires Nike marketing veteran as wearables wars heat up
- The Health App War Is No Longer About the Hardware (2026-03-07)
- WHOOP Unveils WHOOP 5.0 and WHOOP-MG (2025-05-08)
- Will FDA's Warning Letter to WHOOP Put a Chill on Wearables?
- Whoop Lawsuit Claims Blood Pressure Monitors Are Falsely Advertised (2025-11-21)
- Whoop (company) -> Product
- FDA drops enforcement against Whoop after it tweaks blood pressure feature (2026-06-24)
- Whoop Names a Former FDA Committee Chair as New Medical Chief (2026-07-22)